Taipei Medical University (TMU) and National Taiwan University Hospital (NTUH) yesterday announced two research breakthroughs related to precision medical care of liver cancer and chronic kidney disease.
They said at a news conference that they have been collaborating on several projects on precision medical care for liver cancer and kidney diseases, citing that there are more than 90,000 people who are on dialysis in Taiwan.
NTUH superintendent Wu Ming-shiang (吳明賢) said the two hospitals have strong research capacity, so their collaboration can achieve highly effective results.
Photo: Chiu Chih-jou, Taipei Times
That many of the studies were conducted by interdisciplinary or even multinational medical teams shows the strength of Taiwan’s precision medicine to the world, Wu said.
Taiwan historically had a high prevalence of hepatitis B, with carrier rates reaching about one-fifth of the population and many affected by the “hepatitis-cirrhosis-liver cancer” disease progression, NTUH Department of Internal Medicine attending physician Tsai Feng-chiao (蔡丰喬) said.
While vaccination and increased early screening have reduced virus-induced liver cancer cases, metabolic disorders and fatty liver disease continue to pose a serious health threat, Tsai said.
As effective treatment options are limited, some medical teams are looking to develop personalized diagnostic and therapeutic strategies based on a person’s cancer etiology, he said.
Tsai said their team, led by NTUH vice superintendent Kao Jia-horng (高嘉宏) and in partnership with TMU, employed multiomics techniques to investigate variations in the genome, transcriptome and kinome across liver cancer patients.
Their findings explained tumor heterogeneity and its implications for disease progression and treatment response, NTUH said.
Meanwhile, NTUH hepatologist Su Tung-hung (蘇東弘) analyzed a large hepatitis B patient database to identify single nucleotide polymorphisms associated with virus-induced liver cancer, the hospital said.
TMU assistant professor Chang Ching-wen researched how immune microenvironments surrounding tumor cells influence cancer growth and therapeutic outcomes through integrative genomic and transcriptomic profiling, it said.
The joint effort has led to the creation of a comprehensive liver cancer tumor database, which could accelerate the identification of personalized biomarkers and support the realization of precision liver cancer care, it said.
Furthermore, through high-throughput experiments and artificial intelligence analysis, the team developed a “gene interference plus drug inhibition” platform and identified two promising combination therapies which were validated using TMU clinical patient data, it said.
Although the discoveries are not ready for clinical application, they mark major milestones in cancer therapy research, it added.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
The Ministry of Finance this afternoon announced the winning numbers for the March-April uniform invoice lottery. The winning number for the NT$10 million (US$318,060) special prize is 19531471, and the winning number for the NT$2 million grand prize is 85941329. Three numbers were drawn for the NT$200,000 first prize: 07225810, 20231230 and 83518781. Those with receipts matching the last seven digits of any of the first-prize numbers will win the NT$40,000 second prize, while those matching the last six digits will win the NT$10,000 third prize. Those whose receipts match the last five digits of the first-prize numbers can claim the NT$4,000 fourth prize,
SIX SUBSIDIES: The monthly allowance for older farmers is to increase to NT$10,000, and NT$5,000 is to be given to homemakers under the national pension system, Lai said The government is to implement major welfare policies for disadvantaged groups, including raising the monthly allowance for older farmers to NT$10,000 and providing homemakers with NT$5,000 per month, President William Lai (賴清德) said yesterday. Lai made the remarks during a visit to Wangling Temple in Chiayi County, saying that the planned increases were being introduced amid economic growth and an increase in tax revenue. Touting a policy, in which the government plans to provide a monthly allowance of NT$5,000 for every child under the age of 18 in a bid to address Taiwan’s low birthrate, Lai said that if received for the
RSS